A recent study published in The Annals of Thoracic Surgery found that that survival rates have improved among those with early-stage lung cancer.
The study included more than 65,000 people diagnosed with stage 1 non-small-cell lung cancer between 2000 and 2010. Of that group, 62 percent had surgery, 15 percent received radiation therapy, 3 percent had both surgery and radiation and 18 percent received neither treatment. The two-year survival rate for people treated with either surgery or radiation therapy rose from 61 percent in 2000 to 70 percent in 2009, corresponding to a 3.5 percent annual decrease in death from lung cancer.
“More and more patients are being cured of lung cancer, with both surgery and radiation as good treatment options,” said study author Nirav Kapadia, M.D. “Our study optimistically suggests that if current trends persist, survival for non-small-cell lung cancer will continue to improve over time.”
At CyberKnife Center of Chicago, lung cancer patients are treated with stereotactic body radiation therapy (SBRT) using the CyberKnife® Robotic Radiosurgery System. CyberKnife is a painless, nonsurgical outpatient cancer treatment with minimal to no side effects. During the CyberKnife treatment, hundreds of highly concentrated and incredibly precise beams of radiation are targeted directly to tumors and lesions in the lung. As the patient breathes during the CyberKnife treatment, the CyberKnife robotic arm moves with the rise and fall of his/her body, meaning that healthy tissue is protected from radiation and only the tumor is treated.
The staff and physician team at CyberKnife Center of Chicago have years of extensive experience treating lung cancer patients with stereotactic radiation therapy. Lung cancer is the second most treated tumor at Chicago CyberKnife, and the team has treated over 300 lung cancer patients. Combined with highly advanced CyberKnife® technology, Chicago CyberKnife’s expert team delivers quality care in a compassionate manner.
To learn more about how CyberKnife Center of Chicago treats lung cancer with CyberKnife technology, please click here or contact the center today.